Literature DB >> 12435252

Allocation concealment in clinical trials.

Peter Jüni, Matthias Egger.   

Abstract

Mesh：

Year:  2002        PMID： 12435252     DOI： 10.1001/jama.288.19.2407-jlt1120-4-2

Source DB:  PubMed          Journal:  JAMA        ISSN： 0098-7484            Impact factor:   56.272


× No keyword cloud information.
  7 in total

1.  Assessment of methodological quality of primary studies by systematic reviews: results of the metaquality cross sectional study.

Authors:  Lorenzo P Moja; Elena Telaro; Roberto D'Amico; Ivan Moschetti; Laura Coe; Alessandro Liberati
Journal:  BMJ       Date:  2005-04-07

Review 2.  Comparison of descriptions of allocation concealment in trial protocols and the published reports: cohort study.

Authors:  Julie Pildal; An-Wen Chan; Asbjørn Hróbjartsson; Elisabeth Forfang; Douglas G Altman; Peter C Gøtzsche
Journal:  BMJ       Date:  2005-04-07

Review 3.  Cochrane reviews compared with industry supported meta-analyses and other meta-analyses of the same drugs: systematic review.

Authors:  Anders W Jørgensen; Jørgen Hilden; Peter C Gøtzsche
Journal:  BMJ       Date:  2006-10-06

Review 4.  Knowledge transfer in surgery: skills, process and evaluation.

Authors:  Martin Dawes; Marko Lens
Journal:  Ann R Coll Surg Engl       Date:  2007-11       Impact factor: 1.891

5.  Laparoscopic versus conventional open surgery for immune function in patients with colorectal cancer.

Authors:  Chuanyuan Liu; Jungang Liu; Sen Zhang
Journal:  Int J Colorectal Dis       Date:  2011-08-06       Impact factor: 2.571

Review 6.  Sicily statement on evidence-based practice.

Authors:  Martin Dawes; William Summerskill; Paul Glasziou; Antonino Cartabellotta; Janet Martin; Kevork Hopayian; Franz Porzsolt; Amanda Burls; James Osborne
Journal:  BMC Med Educ       Date:  2005-01-05       Impact factor: 2.463

7.  PRISMA-combined α-blockers and antimuscarinics for ureteral stent-related symptoms: A meta-analysis.

Authors:  Yu-Ming Zhang; Pei Chu; Wen-Jin Wang
Journal:  Medicine (Baltimore)       Date:  2017-02       Impact factor: 1.889
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.